Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel
Heather M. Judge(Royal Hallamshire Hospital), Robert F. Storey(University of Sheffield), Robert Buckland(Umeå University), Shankar B. Patil(University of Sheffield), Joseph A. Jakubowski(Indiana Biosciences Research Institute)
Cited by 45
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k
Complete Revascularization with Multivessel PCI for Myocardial Infarction
|New England Journal of Medicine|2019|926